DK1883452T3 - Farmaceutisk sammensætning indeholdende et anti-parasitmiddel og et aktivstof valgt fra thymol, eugenol eller carvacrol - Google Patents
Farmaceutisk sammensætning indeholdende et anti-parasitmiddel og et aktivstof valgt fra thymol, eugenol eller carvacrolInfo
- Publication number
- DK1883452T3 DK1883452T3 DK06755932.8T DK06755932T DK1883452T3 DK 1883452 T3 DK1883452 T3 DK 1883452T3 DK 06755932 T DK06755932 T DK 06755932T DK 1883452 T3 DK1883452 T3 DK 1883452T3
- Authority
- DK
- Denmark
- Prior art keywords
- carvacrol
- thymol
- eugenol
- pharmaceutical composition
- composition containing
- Prior art date
Links
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 title 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 title 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 title 1
- 239000005770 Eugenol Substances 0.000 title 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 title 1
- 239000005844 Thymol Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 230000002141 anti-parasite Effects 0.000 title 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 title 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 title 1
- 235000007746 carvacrol Nutrition 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 229960002217 eugenol Drugs 0.000 title 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229960000790 thymol Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2005/001314 WO2006120495A1 (fr) | 2005-05-13 | 2005-05-13 | Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol |
PCT/IB2006/001441 WO2006120568A2 (fr) | 2005-05-13 | 2006-05-15 | Composition pharmaceutique comprenant un agent antiparasitaire , et un actif choisi parmi le carveol , le thymol , l ugenol , le borneol , le carvacrol , l lpha- ionone ou le beta-ionone |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1883452T3 true DK1883452T3 (da) | 2013-02-25 |
Family
ID=35427309
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06755932.8T DK1883452T3 (da) | 2005-05-13 | 2006-05-15 | Farmaceutisk sammensætning indeholdende et anti-parasitmiddel og et aktivstof valgt fra thymol, eugenol eller carvacrol |
DK06744739.1T DK1879656T3 (da) | 2005-05-13 | 2006-05-15 | Farmaceutisk sammensætning omfattende et antitumoralt middel og en aktiv substans udvalgt fra især carveol, thymol og carvacrol |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06744739.1T DK1879656T3 (da) | 2005-05-13 | 2006-05-15 | Farmaceutisk sammensætning omfattende et antitumoralt middel og en aktiv substans udvalgt fra især carveol, thymol og carvacrol |
Country Status (16)
Country | Link |
---|---|
US (2) | US20080171768A1 (da) |
EP (2) | EP1883452B1 (da) |
JP (1) | JP5073651B2 (da) |
CN (2) | CN101193682B (da) |
AP (1) | AP2437A (da) |
AT (1) | ATE554827T1 (da) |
BR (2) | BRPI0610130A2 (da) |
CA (2) | CA2606887C (da) |
DK (2) | DK1883452T3 (da) |
EA (1) | EA015168B1 (da) |
ES (2) | ES2386292T3 (da) |
MA (2) | MA29573B1 (da) |
PT (2) | PT1883452E (da) |
TN (2) | TNSN07423A1 (da) |
WO (3) | WO2006120495A1 (da) |
ZA (1) | ZA200710785B (da) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008029136A1 (en) * | 2006-09-05 | 2008-03-13 | Ultra Biotech Limited | Pharmaceutical composition and method for cancer treatment based on combinational use of conventional or plant-derived anticancer agents and geranium oil or compounds thereof |
US20080293648A1 (en) * | 2007-01-05 | 2008-11-27 | Saha Pharmaceuticals, Inc. | Compositions and Methods for Cancer Treatment |
US8563554B2 (en) | 2009-03-17 | 2013-10-22 | Concert Pharmaceuticals, Inc. | Deuterated pyrazinoisoquinoline compounds |
EA019746B1 (ru) | 2009-09-24 | 2014-05-30 | Юнилевер Нв | Противомикробная композиция, содержащая эвгенол, терпинеол и тимол, и способ дезинфицирования поверхности |
EA022986B1 (ru) | 2010-12-07 | 2016-04-29 | Юнилевер Нв | Композиция для ухода за полостью рта |
CN103998011B (zh) | 2011-11-03 | 2016-11-23 | 荷兰联合利华有限公司 | 个人清洁组合物 |
CN102579449B (zh) * | 2012-03-30 | 2013-08-07 | 厦门大学 | 一种可提高肿瘤对紫杉醇敏感性的联合用药 |
GB201404505D0 (en) * | 2013-09-06 | 2014-04-30 | Mars Inc | Oral anti-parasitic composition |
CA2959414C (en) | 2014-09-05 | 2023-03-14 | Symbiomix Therapeutics, Llc | Secnidazole for use in the treatment of bacterial vaginosis |
US20180078515A1 (en) * | 2015-03-20 | 2018-03-22 | Sammy Oyoo OPIYO | Use of suramin and arginase inhibitors in malignant neoplasia |
WO2016196653A1 (en) | 2015-06-01 | 2016-12-08 | Symbiomix Therapeutics, Llc | Novel nitroimidazole formulations and uses thereof |
CN105147647A (zh) * | 2015-08-19 | 2015-12-16 | 华南理工大学 | 右旋龙脑作为抗肿瘤药物增敏剂的应用 |
JP7033586B2 (ja) | 2016-06-02 | 2022-03-10 | アドバンスト サイエンティフィック ディヴェロップメンツ | シネオールとアモキシシリンとを含む医薬製剤 |
BR112019020225A2 (pt) * | 2017-03-28 | 2020-04-22 | IRP Health Pty Ltd | alcaloides berberina na prevenção e/ou tratamento de doença intestinal |
CN112972437B (zh) * | 2021-02-19 | 2022-03-25 | 沈阳伟嘉生物技术有限公司 | 一种包含碘硝酚的长效外用制剂及其制备方法和用途 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3634697A1 (de) * | 1986-10-11 | 1988-04-21 | Dentaire Ivoclar Ets | Dentalwerkstoff zur bekaempfung von karies und parodontose |
DE19509697A1 (de) * | 1995-03-08 | 1996-09-12 | Schering Ag | Neue Borneole, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
CA2224227A1 (en) * | 1995-06-07 | 1996-12-19 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
WO2000033858A1 (en) * | 1998-12-07 | 2000-06-15 | Ecosmart Technologies, Inc. | Cancer treatment composition and method using natural plant essential oils with signal transduction modulators |
US6536268B1 (en) * | 1999-11-01 | 2003-03-25 | Siemens Vdo Automotive Corporation | Utilizing increasing width for identification voltages |
DE10007771A1 (de) * | 2000-02-14 | 2001-08-23 | Kleine & Steube Entoxin Gmbh | Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung |
AU2002227913B2 (en) * | 2000-11-09 | 2007-08-02 | Jorg P. Schur | Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect |
US20040092583A1 (en) * | 2001-01-02 | 2004-05-13 | Elizabeth Shanahan-Prendergast | Treatment for inhibiting neoplastic lesions |
US20030064948A1 (en) * | 2001-02-08 | 2003-04-03 | Alfred Fahr | Invasomes for therapy of disorders, their preparation and use |
ATE478684T1 (de) * | 2002-02-20 | 2010-09-15 | Ninkov Dusan Dr | Antimikrobielle therapeutische zusammensetzungen und ihre verwendung |
US20030225003A1 (en) * | 2002-04-18 | 2003-12-04 | Dusan Ninkov | Antimicrobial therapeutic compositions for oral and topical use |
WO2004052308A2 (en) * | 2002-12-10 | 2004-06-24 | Biosynexus Incorporated | Topical anti-infective formulations |
US20040151771A1 (en) * | 2003-02-04 | 2004-08-05 | Gin Jerry B. | Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth |
CN100343223C (zh) * | 2005-03-07 | 2007-10-17 | 常州市智能动物药业有限公司 | 百里酚或香芹酚的酯类化合物、制备方法及其药物活性组合物 |
-
2005
- 2005-05-13 WO PCT/IB2005/001314 patent/WO2006120495A1/fr active Application Filing
-
2006
- 2006-05-15 US US11/914,019 patent/US20080171768A1/en not_active Abandoned
- 2006-05-15 BR BRPI0610130-5A patent/BRPI0610130A2/pt not_active Application Discontinuation
- 2006-05-15 AT AT06744739T patent/ATE554827T1/de active
- 2006-05-15 CN CN2006800203654A patent/CN101193682B/zh not_active Expired - Fee Related
- 2006-05-15 DK DK06755932.8T patent/DK1883452T3/da active
- 2006-05-15 BR BRPI0610123-2A patent/BRPI0610123A2/pt not_active Application Discontinuation
- 2006-05-15 CN CN2006800161609A patent/CN101175532B/zh not_active Expired - Fee Related
- 2006-05-15 PT PT67559328T patent/PT1883452E/pt unknown
- 2006-05-15 DK DK06744739.1T patent/DK1879656T3/da active
- 2006-05-15 ES ES06744739T patent/ES2386292T3/es active Active
- 2006-05-15 JP JP2008510669A patent/JP5073651B2/ja not_active Expired - Fee Related
- 2006-05-15 CA CA2606887A patent/CA2606887C/fr not_active Expired - Fee Related
- 2006-05-15 US US11/914,029 patent/US20080171709A1/en not_active Abandoned
- 2006-05-15 WO PCT/IB2006/001441 patent/WO2006120568A2/fr active Application Filing
- 2006-05-15 ES ES06755932T patent/ES2399348T3/es active Active
- 2006-05-15 WO PCT/IB2006/001328 patent/WO2006120564A1/fr active Application Filing
- 2006-05-15 EA EA200702486A patent/EA015168B1/ru not_active IP Right Cessation
- 2006-05-15 CA CA2608061A patent/CA2608061C/fr not_active Expired - Fee Related
- 2006-05-15 EP EP06755932A patent/EP1883452B1/fr active Active
- 2006-05-15 AP AP2007004228A patent/AP2437A/xx active
- 2006-05-15 PT PT06744739T patent/PT1879656E/pt unknown
- 2006-05-15 EP EP06744739A patent/EP1879656B1/fr active Active
-
2007
- 2007-11-13 TN TNP2007000423A patent/TNSN07423A1/fr unknown
- 2007-11-13 TN TNP2007000426A patent/TNSN07426A1/fr unknown
- 2007-12-12 ZA ZA200710785A patent/ZA200710785B/xx unknown
- 2007-12-28 MA MA30528A patent/MA29573B1/fr unknown
- 2007-12-28 MA MA30531A patent/MA29908B1/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1883452T3 (da) | Farmaceutisk sammensætning indeholdende et anti-parasitmiddel og et aktivstof valgt fra thymol, eugenol eller carvacrol | |
DK1879654T3 (da) | Farmaceutisk kombination af et afsvampningsmiddel og en aktiv substans, som navnlig er eugenol og carvacrol | |
BRPI0810552A2 (pt) | Composição de substância ativa, processos para preparar uma composição de substância ativa, e para preparar sementes contenda substância ativa, uso da composição de substância ativa, sementes, e, composição aquosa. | |
DK3311805T3 (da) | Sammensætninger, der omfatter svært vandopløselige farmaceutiske midler og antimikrobielle midler | |
DK1940459T3 (da) | Fast-opløsningsperforator indeholdende aktivstofpartikel og/eller aktivstof-adsorberede partikler | |
ITBO20050123A1 (it) | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina | |
BRPI0821115A2 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
DK1890681T3 (da) | Törgranuleret sammensætning indeholdende emtricitabin og tenofovir DF | |
CY1109010T1 (el) | γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ | |
PT1879655E (pt) | Composição farmacêutica compreendendo um agente antibacteriano e uma substância activa seleccionada a partir de carveol, carvacrol, alfa-ionona, beta-ionona, e timol | |
IL218840A0 (en) | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof | |
DK1939204T3 (da) | Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse deraf | |
DK1901731T3 (da) | Niacinreceptoragonister, sammensætninger indeholdende sådanne forbindelser og fremgangsmåder til behandling | |
BRPI0814891A2 (pt) | Composição farmacêutica contendo composto oticamente ativo tendo atividade agonista de receptor de trombopoietina, e intermediário do mesmo. | |
CU23779B7 (es) | Compuestos de pirazolina y su uso y composiciones farmacéuticas | |
DK1968990T3 (da) | Vandopløselig benzoazepinforbindelse og farmaceutisk sammensætning deraf | |
BRPI0820673A2 (pt) | Formulações e composições farmacêuticas de fenilefrina para absorção transmucosal | |
BRPI0907650A2 (pt) | Composições farmacêuticas compreendendo degradadores de produtos finais de glicosilação avançada (ages) e drogas adjuvantes como drogas anti-hipertensivas, antidiabéticas e etc | |
BRPI0821373A2 (pt) | Composições farmacêuticas contendo ao menos um princípio ativo protéico protegido de enzimas digestivas | |
DK1745786T3 (da) | Neuroprotektive forbindelser og farmaceutiske præparater, som omfatter dem | |
BRPI0820985A2 (pt) | Composto derivado de 5-aminociclometil-oxazondin-2-ona, medicamento e composição farmacêutica que os contém e uso dos mesmos | |
DK1707564T3 (da) | Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
BRPI0720684A2 (pt) | composto, medicamento, composição farmacêutica que contém e uso do composto | |
DK2024329T3 (da) | (2r)-2-[(4-sulfonyl)aminophenyl]propanamider og farmaceutiske sammensætninger indeholdende dem | |
BRPI0910570A2 (pt) | uso de bioconjugados, e, formulações farmacêuticas |